1. Home
  2. CMPS

as 12-20-2024 3:33pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

Founded: 2020 Country:
United Kingdom
United Kingdom
Employees: N/A City: CHESIRE
Market Cap: 280.2M IPO Year: 2020
Target Price: $33.60 AVG Volume (30 days): 705.9K
Analyst Decision: Strong Buy Number of Analysts: 6
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.19 EPS Growth: N/A
52 Week Low/High: $3.85 - $12.75 Next Earning Date: 10-31-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

CMPS Daily Stock ML Predictions

Stock Insider Trading Activity of COMPASS Pathways Plc American Depository Shares (CMPS)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
ATAI Life Sciences N.V. CMPS 10% Owner Sep 26 '24 Sell $6.05 2,660,000 $16,093,000.00 6,905,774

Share on Social Networks: